Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trial
-
Published:2023-07
Issue:1
Volume:87
Page:18-26
-
ISSN:0163-4453
-
Container-title:Journal of Infection
-
language:en
-
Short-container-title:Journal of Infection
Author:
Liu Xinxue, Munro Alasdair P S, Wright AnnieORCID, Feng Shuo, Janani Leila, Aley Parvinder K, Babbage Gavin, Baker Jonathan, Baxter David, Bawa Tanveer, Bula Marcin, Cathie Katrina, Chatterjee Krishna, Dodd Kate, Enever YvanneORCID, Fox Lauren, Qureshi Ehsaan, Goodman Anna L., Green Christopher A, Haughney John, Hicks Alexander, Jones Christine E, Kanji Nasir, van der Klaauw Agatha A., Libri Vincenzo, Llewelyn Martin J, Mansfield Rebecca, Maallah Mina, McGregor Alastair C, Minassian Angela M., Moore Patrick, Mughal Mehmood, Mujadidi Yama F, Belhadef Hanane Trari, Holliday Kyra, Osanlou Orod, Osanlou Rostam, Owens Daniel R, Pacurar Mihaela, Palfreeman Adrian, Pan Daniel, Rampling Tommy, Regan Karen, Saich Stephen, Saralaya Dinesh, Sharma Sunil, Sheridan Ray, Stokes Matthew, Thomson Emma C, Todd Shirley, Twelves Chris, Read Robert C., Charlton Sue, Hallis Bassam, Ramsay Mary, Andrews Nick, Lambe Teresa, Nguyen-Van-Tam Jonathan S, Cornelius Victoria, Snape Matthew D, Faust Saul N
Subject
Infectious Diseases,Microbiology (medical)
Reference20 articles.
1. World Health Organisation. Interim statement on the use of additional booster doses of Emergency Use Listed mRNA vaccines against COVID-19; 2022. Available from: 〈https://www.who.int/news/item/17–05-2022-interim-statement-on-the-use-of-additional-booster-doses-of-emergency-use-listed-mrna-vaccines-against-covid-19〉. 2. Our World in Data. United States: coronavirus pandemic country profile; 2022. Available from: 〈https://ourworldindata.org/coronavirus/country/united-states〉. 3. Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial;Munro;Lancet,2021 4. Homologous and heterologous Covid-19 booster vaccinations;Atmar;N Engl J Med,2022 5. Vaccine induced immune thrombocytopenia and thrombosis: summary of NICE guidance;Pavord;BMJ,2021
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|